Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pyridostigmine bromide 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridostigmine bromide 60mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridostigine bromide 180mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridostigmine bromide 60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridostigine bromide 10mg/2mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridostigmine bromide 5mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine bromide 180 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine bromide 180 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine bromide 5 mg/mL solution for injection |
Has precise active ingredient |
True |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridostigmine bromide 5 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Pyridostigmine bromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |